Trends in the diagnosis and management of TTP: European perspective.

Abstract

Thrombotic thrombocytopenic purpura diagnosis and therapy has transformed with improved understanding of the disorder and availability of therapies. Plasma exchange remains the cornerstone of treatment. Prompt therapy can improves morbidity and mortality. However, given the plasma volumes used, those offering protection against transfer of microbes are preferable. Reviewed is a brief history of TTP and current plasmas available, their use and safety profiles, concentrating on the current UK recommendations.

• Authors: Marie Scully
• Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis (Transfus Apher Sci) Vol. 51 Issue 1 Pg. 11-4 (Aug 2014) ISSN: 1473-0502 [Print] England
• PMID: 25305101 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2014. Published by Elsevier Ltd.

Topics

• Humans
• Plasma Exchange
• Purpura, Thrombotic Thrombocytopenic (diagnosis, mortality, therapy)
• United Kingdom